adenine has been researched along with dabigatran in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Campello, E; Imbergamo, S; Piazza, F; Pravato, S; Scomazzon, E; Semenzato, G; Simioni, P; Spiezia, L; Trentin, L; Visentin, A | 1 |
| Dąbrowska-Kugacka, A; Daniluk, P; Lasocka, Z; Lewicka, E; Nabiałek-Trojanowska, I; Zarzycka, E; Zaucha, JM | 1 |
| Falbo, M; Iannaccaro, P; Levato, L; Prejanò, S; Santoro, RC | 1 |
3 other study(ies) available for adenine and dabigatran
| Article | Year |
|---|---|
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases.
Topics: Adenine; Aged; Aged, 80 and over; Atrial Fibrillation; Dabigatran; Female; Humans; Lymphoproliferative Disorders; Piperidines; Pyrazoles; Pyrimidines | 2018 |
Assessment of dabigatran plasma concentration may improve the safety of anticoagulation in patients treated with ibrutinib with concomitant atrial fibrillation.
Topics: Adenine; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Piperidines; Plasma; Stroke; Treatment Outcome | 2020 |
Dabigatran in ibrutinib-treated patients with atrial fibrillation and chronic lymphocytic leukemia: experience of three cases.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Aged; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors | 2021 |